JW (Cayman) Therapeutics
$0.31
0
-$0.05-13.55% Monday 20:00
Statistics
Day High
0.36
Day Low
0.34
52W High
0.66
52W Low
0.16
Volume
33,000
Avg. Volume
2,296
Mkt Cap
127.78M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
26MarExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-373.19%Profit Margin
Unprofitable43.42MRevenue
-162.02MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow JWCTF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, the People's Republic of China.
Show more...
CEO
Mr. Min Liu
Employees
281
Country
US
ISIN
KYG5210T1040
Listings
0 Comments
Share your thoughts
FAQ
What is JW (Cayman) Therapeutics stock price today?▼
The current price of JWCTF is $0.31 USD — it has decreased by -13.55% in the past 24 hours. Watch JW (Cayman) Therapeutics stock price performance more closely on the chart.
What is JW (Cayman) Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange JW (Cayman) Therapeutics stocks are traded under the ticker JWCTF.
What is JW (Cayman) Therapeutics market cap?▼
Today JW (Cayman) Therapeutics has the market capitalization of 127.78M
When is the next JW (Cayman) Therapeutics earnings date?▼
JW (Cayman) Therapeutics is going to release the next earnings report on September 01, 2026.
What is JW (Cayman) Therapeutics revenue for the last year?▼
JW (Cayman) Therapeutics revenue for the last year amounts to 43.42M USD.
What is JW (Cayman) Therapeutics net income for the last year?▼
JWCTF net income for the last year is -162.02M USD.
How many employees does JW (Cayman) Therapeutics have?▼
As of April 03, 2026, the company has 281 employees.
In which sector is JW (Cayman) Therapeutics located?▼
JW (Cayman) Therapeutics operates in the Health Care sector.
When did JW (Cayman) Therapeutics complete a stock split?▼
JW (Cayman) Therapeutics has not had any recent stock splits.
Where is JW (Cayman) Therapeutics headquartered?▼
JW (Cayman) Therapeutics is headquartered in Shanghai, US.